EMN — Stock Film
STOCK FILMSCENE 1/11EMN · $68.08
Stock Expert AI presents
EMN
Eastman Chemical Company
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Eastman Chemical Company. A quick introduction.

On the stock market since 1993, it operates in the world of raw materials. It has 13,000 employees. Now — the numbers.

on the stock market since 1993
13K employees
$7.8B market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $5 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 5%

This is an established company with proven profits.

WHERE DOES THE MONEY COME FROM?
33%Additives and Functional Products
Additives and Functional Products 33%Advanced Materials 33%Chemical Intermediates 22%Fibers 12%
33% of all revenue comes from a single line: Additives and Functional Products.

Revenue is spread across several lines; no single product carries the company.

Cash on hand:
$0
Total debt:
$0
The debt outweighs the cash.

The gap is $4.5B. In times of high interest rates, a gap like that can squeeze a company.

What executives did with their own stock over the last 12 months:
70 buy17 sell

Executives buying with their own money is usually read as confidence in the company’s future.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
57
average

Profit indicators sit around the sector average.

FINANCIAL STRENGTH
30
very weak

Clearly below the class average.

VALUATION
91
very strong

The price looks reasonable next to what the company earns.

GROWTH
41
weak

Clearly below the class average.

PRICE MOMENTUM
49
weak

Clearly below the class average.

WORTH WATCHING

Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.

Growth: Sales growth trails the sector average.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 47% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/3
Executives are buying their own stock

Over the last 12 months, company executives reported 70 buys and 17 sells. Management buying with its own money is usually read as a good sign.

2
THE BRIGHT SIDE · 2/3
Analysts’ target sits above today’s price

The average analyst price target is $79.5617% above today’s price.

3
THE BRIGHT SIDE · 3/3
Pays a steady dividend

It pays out $3.35 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/3
Sales are shrinking

Over the last 3 years, sales fell about 6% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.

2
THE RISKS · 2/3
A thin financial cushion

The balance sheet offers little cushion against a rough stretch. Report-card grade: 30/100.

3
THE RISKS · 3/3
Growth trails the sector

The growth engine is running at low revs right now. Report-card grade: 41/100.

FINALE · THE GRADE
C
0 / 100 · MoonshotScore

On our five-subject report card, EMN sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.

The takeaway: EMN is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film